Skip to main content
. 2021 Apr 12;5(3):pkab025. doi: 10.1093/jncics/pkab025

Figure 2.

Figure 2.

Kaplan-Meier plots of progression-free survival (A) and overall survival (B) by body mass index (BMI). Two-sided stratified log-rank test was used with stratification factors including treatment assignment, hormone receptor status, prior taxane, and use of bevacizumab.